156 related articles for article (PubMed ID: 27858866)
1. The ERCC1-4533/8092, TNF-α 238/308 polymorphisms and the risk of hepatocellular carcinoma in Guangxi Zhuang populations of China: Case-control study.
Li Y; Ou C; Shu H; Zhao H; Zhu B
Medicine (Baltimore); 2016 Nov; 95(44):e5217. PubMed ID: 27858866
[TBL] [Abstract][Full Text] [Related]
2. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
3. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
Huang YL; Wu JR; Fang M; Zhao HL; Liu ZM; Ye J; Huang LS; Zhu B
Medicine (Baltimore); 2019 Apr; 98(14):e15090. PubMed ID: 30946366
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha gene -308G > A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population.
Feng H; Kuai JH; Zhang MY; Wang GC; Shi YJ; Zhang JY
Diagn Pathol; 2014 Nov; 9():199. PubMed ID: 25420786
[TBL] [Abstract][Full Text] [Related]
5. Association analysis between the c.1804C>A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population.
Liu Y; Zhang A; Liu Y; Dong J
Med Oncol; 2014 Mar; 31(3):854. PubMed ID: 24526467
[TBL] [Abstract][Full Text] [Related]
6. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
7. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.
Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z
Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872
[TBL] [Abstract][Full Text] [Related]
8. Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study.
Huang L; Liu C; Deng Y; Liu Y; Zhao J; Huang X; Tang W; Sun Y; Qin X; Li S
PLoS One; 2016; 11(7):e0158241. PubMed ID: 27384772
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha 308 G/A polymorphism and hepatocellular carcinoma risk in a Chinese population.
Shi Z; Du C
Genet Test Mol Biomarkers; 2011; 15(7-8):569-72. PubMed ID: 21401328
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
[TBL] [Abstract][Full Text] [Related]
11. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
Bi J; Zhong C; Li K; Chu H; Wang B
Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
[TBL] [Abstract][Full Text] [Related]
12. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
Long XD; Ma Y; Zhou YF; Ma AM; Fu GH
Hepatology; 2010 Oct; 52(4):1301-9. PubMed ID: 20658464
[TBL] [Abstract][Full Text] [Related]
14. Association Between Polymorphisms in CMTM Family Genes and Hepatocellular Carcinoma in Guangxi of China.
Bei C; Tan C; Zhu X; Wang Z; Tan S
DNA Cell Biol; 2018 Aug; 37(8):691-696. PubMed ID: 29990439
[TBL] [Abstract][Full Text] [Related]
15. DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China.
Zeng X; Liu S; Yu H; Ji L; Li L; Huang J; Bai H; Qiu X
DNA Cell Biol; 2012 Aug; 31(8):1384-91. PubMed ID: 22691054
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population.
Jiang T; Cui L; Chen L; Liu Z; Ren H
Med Oncol; 2014 Apr; 31(4):887. PubMed ID: 24570146
[TBL] [Abstract][Full Text] [Related]
17. Association study of c.910A>G and c.1686C>G polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in the Chinese population.
Xia WF; Ma XP; Li XR; Dong H; Yi JL
Genet Mol Res; 2014 Feb; 13(1):1314-22. PubMed ID: 24634229
[TBL] [Abstract][Full Text] [Related]
18. Association Between P2RX7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Chinese Han Population.
Duan S; Yu J; Han Z; Cheng Z; Liang P
Med Sci Monit; 2016 Jun; 22():1916-23. PubMed ID: 27272229
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.
Liu Y; Sui J; Zhai L; Yang S; Huang L; Huang L; Mo C; Wu J; Li S; Qin X
Med Oncol; 2014 Oct; 31(10):200. PubMed ID: 25195037
[TBL] [Abstract][Full Text] [Related]
20. Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population.
Ma H; Xu L; Yuan J; Shao M; Hu Z; Wang F; Wang Y; Yuan W; Qian J; Wang Y; Xun P; Liu H; Chen W; Yang L; Jin G; Huo X; Chen F; Shugart YY; Jin L; Wei Q; Wu T; Shen H; Huang W; Lu D
Pharmacogenet Genomics; 2007 Jun; 17(6):417-23. PubMed ID: 17502833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]